Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state

Neuropharmacology

Volumn 83, Issue , 2014, Pages 36-53

  Jantas, D ^a   Greda, A ^a   Golda, S ^a   Korostynski, M ^a   Grygier, B ^a   Roman, A ^a   Pilc, A ^a   Lason, W ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(S) 3,4 DCPG; ACPT I; AMN082; AZ12216052; LY354740; mGluR II IIIexpression; Necrostatin 1; VU0361737

Indexed keywords

1 AMINOCYCLOPENTANE 1,3,4 TRICARBOXYLIC ACID; 3,4 DICARBOXYPHENYLGLYCINE; ACPT 1; AMN 082; AZ 12216052; CASPASE 3; EGLUMETAD; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; N (4 CHLORO 3 METHOXYPHENYL) 2 PYRIDINECARBOXAMIDE; N,N' DIBENZHYDRYLETHANE 1,2 DIAMINE; NECROSTATIN 1; RETINOIC ACID; UNCLASSIFIED DRUG; VU 0361737; 1 METHYL 4 PHENYLPYRIDINIUM; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 7; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA; NEUROPROTECTION; PRIORITY JOURNAL; AGONISTS; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; TOXICITY; TUMOR CELL LINE;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 84898820425     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.03.019     Document Type: Article

References (103)

1. F.C. Acher, F.J. Tellier, R. Azerad, I.N. Brabet, L. Fagni, and J.P. Pin Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes J. Med. Chem. 40 1997 3119 3129 (Pubitemid 27391544)
2. M. Amalric, S. Lopez, C. Goudet, G. Fisone, G. Battaglia, F. Nicoletti, J.P. Pin, and F.C. Acher Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease Neuropharmacology 66 2013 53 64
3. G. Battaglia, G. Molinaro, B. Riozzi, M. Storto, C.L. Busceti, P. Spinsanti, D. Bucci, V. Di Liberto, G. Mudò, C. Corti, M. Corsi, F. Nicoletti, N. Belluardo, and V. Bruno Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons PLoS One 4 2009 e6591
4. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172 (Pubitemid 32524182)
5. P. Bonsi, D. Cuomo, B. Picconi, G. Sciamanna, A. Tscherter, M. Tolu, G. Bernardi, P. Calabresi, and A. Pisani Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease Amino Acids 32 2007 189 195 (Pubitemid 46198742)
6. S.R. Bradley, D.G. Standaert, A.I. Levey, and P.J. Conn Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies Ann. N. Y. Acad. Sci. 868 1999 531 534 (Pubitemid 29281161)
7. V. Bruno, G. Battaglia, I. Ksiazek, H. van der Putten, M.V. Catania, R. Giuffrida, S. Lukic, T. Leonhardt, W. Inderbitzin, F. Gasparini, R. Kuhn, D.R. Hampson, F. Nicoletti, and P.J. Flor Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death J. Neurosci. 20 2000 6413 6420
8. V. Bruno, F.X. Sureda, M. Storto, G. Casabona, A. Caruso, T. Knopfel, R. Kuhn, and F. Nicoletti The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling J. Neurosci. 17 1997 1891 1897 (Pubitemid 27106748)
9. V. Bruno, G. Battaglia, A. Copani, R.G. Giffard, G. Raciti, R. Raffaele, H. Shinozaki, and F. Nicoletti Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration Eur. J. Neurosci. 7 1995 1906 1913
10. K.R. Byrnes, D.J. Loane, and A.I. Faden Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders Neurotherapeutics 6 2009 94 107
11. P. Calabresi, M. Di Filippo, A. Gallina, Y. Wang, J.N. Stankowski, B. Picconi, V.L. Dawson, and T.M. Dawson New synaptic and molecular targets for neuroprotection in Parkinson's disease Mov. Disord. 28 2013 51 60
12. A.M. Canudas, V. Di Giorgi-Gerevini, L. Iacovelli, G. Nano, M. D'Onofrio, A. Arcella, F. Giangaspero, C. Busceti, L. Ricci-Vitiani, G. Battaglia, F. Nicoletti, and D. Melchiorri PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors J. Neurosci. 24 2004 10343 10352 (Pubitemid 39552618)
13. F. Caraci, G. Battaglia, M.A. Sortino, S. Spampinato, G. Molinaro, A. Copani, F. Nicoletti, and V. Bruno Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic? Neurochem Int. 61 2012 559 565
14. S.M. Cardoso, P.I. Moreira, P. Agostinho, C. Pereira, and C.R. Oliveira Neurodegenerative pathways in Parkinson's disease: therapeutic strategies Curr. Drug. Targets CNS Neurol. Disord. 4 2005 405 419 (Pubitemid 41086758)
15. H.J. Chang, B.C. Yoo, S.B. Lim, S.Y. Jeong, W.H. Kim, and J.G. Park Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance Clin. Cancer Res. 11 2005 3288 3295 (Pubitemid 40627877)
16. K.R. Chaudhuri, and A.H. Schapira Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment Lancet Neurol. 8 2009 464 474
17. R. Chavez-Valdez, L.J. Martin, D.L. Flock, and F.J. Northington Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia Neuroscience 219 2012 192 203
18. N. Chen, and M.E. Reith Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells J. Neurochem 101 2007 377 388 (Pubitemid 46525278)
19. Y.T. Cheung, W.K. Lau, M.S. Yu, C.S. Lai, S.C. Yeung, K.F. So, and R.C. Chang Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research Neurotoxicology 30 2009 127 135
20. W.S. Choi, S.Y. Yoon, T.H. Oh, E.J. Choi, K.L. O'Malley, and Y.J. Oh Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK J. Neurosci. Res. 57 1999 86 94 (Pubitemid 29293582)
21. D.E. Christofferson, and J. Yuan Necroptosis as an alternative form of programmed cell death Curr. Opin. Cell. Biol. 22 2010 263 268
22. C.T. Chu, J.H. Zhu, G. Cao, A. Signore, S. Wang, and J. Chen Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells J. Neurochem 94 2005 1685 1695 (Pubitemid 41324649)
23. P.J. Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat. Rev. Drug. Discov. 8 2009 41 54
24. P.J. Conn, G. Battaglia, M.J. Marino, and F. Nicoletti Metabotropic glutamate receptors in the basal ganglia motor circuit Nat. Rev. Neurosci. 6 2005 787 798 (Pubitemid 41679241)
25. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
26. A. Degterev, J. Hitomi, M. Germscheid, I.L. Ch'en, O. Korkina, X. Teng, D. Abbott, G.D. Cuny, C. Yuan, G. Wagner, S.M. Hedrick, S.A. Gerber, A. Lugovskoy, and J. Yuan Identification of RIP1 kinase as a specific cellular target of necrostatins Nat. Chem. Biol. 4 2008 313 321 (Pubitemid 351550892)
27. A. Degterev, Z. Huang, M. Boyce, Y. Li, P. Jagtap, N. Mizushima, G.D. Cuny, T.J. Mitchison, M.A. Moskowitz, and J. Yuan Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury Nat. Chem. Biol. 1 2005 112 119
28. L. Delavallée, L. Cabon, P. Galán-Malo, H.K. Lorenzo, and S.A. Susin AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics IUBMB Life 63 2011 221 232
29. D.T. Dexter, and P. Jenner Parkinson disease: from pathology to molecular disease mechanisms Free Radic. Biol. Med. 62 2013 132 144
30. Z. Duan, X. Zhang, G.X. Zhu, Y. Gao, and X. Xue Activation of mGluR4 promotes proliferation of rat neural progenitor cells while mediating activation of ERK1/2 signaling pathway Cell. Mol. Biol. (Noisy-le-grand) 59 Suppl. 2013 OL1809 1817
31. S. Duty, and P. Jenner Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease Br. J. Pharmacol. 164 2011 1357 1391
32. S. Duty Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease Br. J. Pharmacol. 161 2010 271 287
33. R.M. Duvoisin, T. Pfankuch, J.M. Wilson, J. Grabell, V. Chhajlani, D.G. Brown, E. Johnson, and J. Raber Acute pharmacological modulation of mGluR8 reduces measures of anxiety Behav. Brain Res. 212 2010 168 173
34. A.I. Faden, and B. Stoica Neuroprotection: challenges and opportunities Arch. Neurol. 64 2007 794 800 (Pubitemid 46919833)
35. C.P. Fall, and J.P. Bennett Jr. Characterization and time course of MPP+ -induced apoptosis in human SH-SY5Y neuroblastoma cells J. Neurosci. Res. 55 1999 620 628 (Pubitemid 29117620)
36. G.H. Fan, C. Qi, and S.D. Chen Heat shock proteins reduce toxicity of 1-methyl-4-phenylpyridinium ion in SK-N-SH cells J. Neurosci. Res. 82 2005 551 562 (Pubitemid 41579355)
37. A. Faria, R. Monteiro, D. Pestana, F. Martel, V. de Freitas, N. Mateus, and C. Calhau Impact of culture media glucose levels on the intestinal uptake of organic cations Cytotechnology 62 2010 23 29
38. S.S. Ferguson Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling Pharmacol. Rev. 53 2001 1 24 (Pubitemid 32173106)
39. F. Ferraguti, and R. Shigemoto Metabotropic glutamate receptors Cell. Tissue Res. 326 2006 483 504 (Pubitemid 44435821)
40. T.M. Fountaine, and R. Wade-Martins RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport J. Neurosci. Res. 85 2007 351 363 (Pubitemid 46219303)
41. C. Gómez, J. Reiriz, M. Piqué, J. Gil, I. Ferrer, and S. Ambrosio Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells J. Neurosci. Res. 63 2001 421 428 (Pubitemid 32184342)
42. J.S. Han, G.C. Bird, and V. Neugebauer Enhanced group III mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala Neuropharmacology 46 2004 918 926 (Pubitemid 38471945)
43. R.A. Hauser New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy Park. Relat. Disord. 15 Suppl. 3 2009 S17 S21
44. T. Hruz, O. Laule, G. Szabo, F. Wessendorp, S. Bleuler, L. Oertle, P. Widmayer, W. Gruissem, and P. Zimmermann Genevestigator V3: a reference expression database for the meta-analysis of transcriptomes Adv. Bioinforma. 2008 420747
45. L. Iacovelli, F. Nicoletti, and A. De Blasi Molecular mechanisms that desensitize metabotropic glutamate receptor signaling: an overview Neuropharmacology 66 2013 24 30
46. L. Iacovelli, A. Arcella, G. Battaglia, S. Pazzaglia, E. Aronica, P. Spinsanti, A. Caruso, E. De Smaele, A. Saran, A. Gulino, M. D'Onofrio, F. Giangaspero, and F. Nicoletti Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas J. Neurosci. 26 2006 8388 8397 (Pubitemid 44309853)
47. L. Iacovelli, L. Capobianco, M. Iula, V. Di Giorgi Gerevini, A. Picascia, J. Blahos, D. Melchiorri, F. Nicoletti, and A. De Blasi Regulation of mGlu4 metabotropic glutamate receptor signaling by type-2 G-protein coupled receptor kinase (GRK2) Mol. Pharmacol. 65 2004 1103 1110 (Pubitemid 38543481)
48. D. Jantas, A. Roman, J. Kuśmierczyk, E. Lorenc-Koci, J. Konieczny, T. Lenda, and W. Lason The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions Neurotox. Res. 24 2013 41 54
49. D. Jantas, E. Lorenc-Koci, M. Kubera, and W. Lason Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons Neurotoxicology 32 2011 845 856
50. D. Jantas, M. Pytel, J.W. Mozrzymas, M. Leskiewicz, M. Regulska, L. Antkiewicz-Michaluk, and W. Lason The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells Neurochem Int. 52 2008 864 877
51. L. Jaworska-Feil, D. Jantas, M. Leskiewicz, B. Budziszewska, M. Kubera, A. Basta-Kaim, W. Lipkowski, and W. Lason Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells Neuropeptide 44 2010 495 508
52. D. Ji, T.A. Kamalden, S. del Olmo-Aguado, and N.N. Osborne Light- and sodium azide-induced death of RGC-5 cells in culture occurs via different mechanisms Apoptosis 16 2011 425 437
53. Q. Jiang, Z. Yan, and J. Feng Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism J. Neurosci. 26 2006 4318 4328 (Pubitemid 44315391)
54. K.A. Johnson, C.K. Jones, M.N. Tantawy, M. Bubser, M. Marvanova, M.S. Ansari, R.M. Baldwin, P.J. Conn, and C.M. Niswender The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease Neuropharmacology 66 2013 187 195
55. N. Joza, J.A. Pospisilik, E. Hangen, T. Hanada, N. Modjtahedi, and J.M. Penninger AIF: not just an apoptosis-inducing factor Ann. N. Y. Acad. Sci. 1171 2009 2 11
56. J.A. Korecka, R.E. van Kesteren, E. Blaas, S.O. Spitzer, J.H. Kamstra, A.B. Smit, D.F. Swaab, J. Verhaagen, and K. Bossers Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling PLoS One 8 2013 e63862
57. S. Krantic, N. Mechawar, S. Reix, and R. Quirion Apoptosis-inducing factor: a matter of neuron life and death Prog. Neurobiol. 81 2007 179 196 (Pubitemid 46282274)
58. H. Lavreysen, and F.M. Dautzenberg Therapeutic potential of group III metabotropic glutamate receptors Curr. Med. Chem. 15 2008 671 684 (Pubitemid 351516803)
59. R.J. Lefkowitz, and S.K. Shenoy Transduction of receptor signals by beta-arrestins Science 308 2005 512 517
60. L.F. Lin, D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1993 1130 1132 (Pubitemid 23186789)
61. F.M. Lopes, R. Schröder, M.L. da Frota Jr., A. Zanotto-Filho, C.B. Müller, A.S. Pires, R.T. Meurer, G.D. Colpo, D.P. Gelain, F. Kapczinski, J.C. Moreira, C. Fernandes Mda, and F. Klamt Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies Brain Res. 1337 2010 85 94
62. S. Lopez, N. Turle-Lorenzo, T.H. Johnston, J.M. Brotchie, S. Schann, P. Neuville, and M. Amalric Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats Neuropharmacology 55 2008 483 490
63. S. Lopez, N. Turle-Lorenzo, F. Acher, E. De Leonibus, A. Mele, and M. Amalric Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease J. Neurosci. 27 2007 6701 6711 (Pubitemid 46983444)
64. D.W. Luchtman, and C. Song Why SH-SY5Y cells should be differentiated Neurotoxicology 31 2010 164 165
65. K. Maiese, Z.Z. Chong, Y.C. Shang, and J. Hou Therapeutic promise and principles Oxid. Med. Cell. Longev. 1 2008 1 14
66. K. Maiese, A. Vincent, S.H. Lin, and T. Shaw Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection J. Neurosci. Res. 62 2000 257 272
67. F. Mela, M. Marti, A. Dekundy, W. Danysz, M. Morari, and M.A. Cenci Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease J. Neurochem 101 2007 483 497 (Pubitemid 46525288)
68. M.J. Messenger, L.G. Dawson, and S. Duty Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract Neuropharmacology 43 2002 261 271 (Pubitemid 35247614)
69. M. Miloso, D. Villa, M. Crimi, S. Galbiati, E. Donzelli, G. Nicolini, and G. Tredici Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent J. Neurosci. Res. 75 2004 241 252 (Pubitemid 38049395)
70. J.A. Monn, M.J. Valli, S.M. Massey, R.A. Wright, C.R. Salhoff, B.G. Johnson, T. Howe, C.A. Alt, G.A. Rhodes, R.L. Robey, K.R. Griffey, J.P. Tizzano, M.J. Kallman, D.R. Helton, and D.D. Schoepp Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6- dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties J. Med. Chem. 40 1997 528 537 (Pubitemid 27080033)
71. J. Naarala, P. Nykvist, M. Tuomala, and K. Savolainen Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells FEBS Lett. 330 1993 222 226 (Pubitemid 23265136)
72. A. Navarro, and A. Boveris Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease J. Bioenerg. Biomembr. 41 2009 517 521
73. F. Nicoletti, J. Bockaert, G.L. Collingridge, P.J. Conn, F. Ferraguti, D.D. Schoepp, J.T. Wroblewski, and J.P. Pin Metabotropic glutamate receptors: from the workbench to the bedside Neuropharmacology 60 2011 1017 1041
74. C.M. Niswender, and P.J. Conn Metabotropic glutamate receptors: physiology, pharmacology, and disease Annu Rev. Pharmacol. Toxicol. 50 2010 295 322
75. C.M. Niswender, K.A. Johnson, C.D. Weaver, C.K. Jones, Z. Xiang, Q. Luo, A.L. Rodriguez, J.E. Marlo, T. de Paulis, A.D. Thompson, E.L. Days, T. Nalywajko, C.A. Austin, M.B. Williams, J.E. Ayala, R. Williams, C.W. Lindsley, and P.J. Conn Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 Mol. Pharmacol. 74 2008 1345 1358
76. F.J. Northington, R. Chavez-Valdez, and L.J. Martin Neuronal cell death in neonatal hypoxia-ischemia Ann. Neurol. 69 2011 743 758
77. S. Orrenius, P. Nicotera, and B. Zhivotovsky Cell death mechanisms and their implications in toxicology Toxicol. Sci. 119 2011 3 19
78. J. Paz, H. Yao, H.S. Lim, X.Y. Lu, and W. Zhang The neuroprotective role of attractin in neurodegeneration Neurobiol. Aging 28 2007 1446 1456 (Pubitemid 47081236)
79. K.A. Pelkey, X. Yuan, G. Lavezzari, K.W. Roche, and C.J. McBain mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082 Neuropharmacology 52 2007 108 117 (Pubitemid 46026829)
80. S.P. Presgraves, A. Tariq, S. Borwege, and J.N. Joyce Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists Neurotox. Res. 5 2004 579 598
81. D.M. Rosenbaum, A. Degterev, J. David, P.S. Rosenbaum, S. Roth, J.C. Grotta, G.D. Cuny, J. Yuan, and S.I. Savitz Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model J. Neurosci. Res. 88 2010 1569 1576
82. L. Schneider, S. Giordano, B.R. Zelickson, S. Johnson M, A. Benavides, G., X. Ouyang, N. Fineberg, V.M. Darley-Usmar, and J. Zhang Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress Free Radic. Biol. Med. 51 2011 2007 2017
83. D.D. Schoepp, B.G. Johnson, R.A. Wright, C.R. Salhoff, N.G. Mayne, S. Wu, S.L. Cockerman, J.P. Burnett, R. Belegaje, D. Bleakman, and J.A. Monn LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors Neuropharmacology 36 1997 1 11 (Pubitemid 27115837)
84. J. Šimenc, and M. Lipnik-Štangelj Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes Drug. Chem. Toxicol. 35 2012 399 405
85. A. Stepulak, H. Luksch, C. Gebhardt, O. Uckermann, J. Marzahn, M. Sifringer, W. Rzeski, C. Staufner, K.S. Brocke, L. Turski, and C. Ikonomidou Expression of glutamate receptor subunits in human cancers Histochem Cell. Biol. 132 2009 435 445
86. F.L. Sun, L. Zhang, R.Y. Zhang, and L. Li Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity Eur. J. Pharmacol. 660 2011 283 290
87. N. Takahashi, L. Duprez, S. Grootjans, A. Cauwels, W. Nerinckx, J.B. DuHadaway, V. Goossens, R. Roelandt, F. Van Hauwermeiren, C. Libert, W. Declercq, N. Callewaert, G.C. Prendergast, A. Degterev, J. Yuan, and P. Vandenabeele Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models Cell. Death Dis. 3 2012 e437
88. S. Tavares, J. Sousa, P. Gonçalves, J.R. Araújo, and F. Martel The effect of folate status on the uptake of physiologically relevant compounds by Caco-2 cells Eur. J. Pharmacol. 640 2010 29 37
89. N. Vanlangenakker, T. Vanden Berghe, and P. Vandenabeele Many stimuli pull the necrotic trigger, an overview Cell. Death Differ. 19 2012 75 86
90. K. Venderova, and D.S. Park Programmed cell death in Parkinson's disease Cold Spring Harb. Perspect. Med. 2 2012 pii:a009365
91. A.C. Vernon, E.J. Smith, L. Stevanato, and M. Modo Selective activation of metabotropic glutamate receptor 7 induces inhibition of cellular proliferation and promotes astrocyte differentiation of ventral mesencephalon human neural stem/progenitor cells Neurochem Int. 59 2011 421 431
92. A.M. Vincent, and K. Maiese The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death Exp. Neurol. 166 2000 65 82
93. A.M. Vincent, M. Ten Broeke, and K. Maiese Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH Exp. Neurol. 155 1999 79 94 (Pubitemid 29072607)
94. W.Y. Wang, H. Wang, Y. Luo, L.J. Jia, J.N. Zhao, H.H. Zhang, Z.W. Ma, Q.S. Xue, and B.W. Yu The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway Neuroscience 205 2012 167 177
95. X.J. Wang, and J.X. Xu Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity Neurosci. Res. 51 2005 129 138
96. Y.Q. Wang, L. Wang, M.Y. Zhang, T. Wang, H.J. Bao, W.L. Liu, D.K. Dai, L. Zhang, P. Chang, W.W. Dong, X.P. Chen, and L.Y. Tao Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model Neurochem Res. 37 2012 1849 1858
97. S.D. Wenker, M.E. Chamorro, D.M. Vota, M.A. Callero, D.C. Vittori, and A.B. Nesse Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells J. Cell. Biochem 110 2010 151 161
98. S.S. Willard, and S. Koochekpour Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications Int. J. Biol. Sci. 9 2013 728 742
99. X. Xu, C.C. Chua, J. Kong, R.M. Kostrzewa, U. Kumaraguru, R.C. Hamdy, and B.H. Chua Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells J. Neurochem. 103 2007 2004 2014 (Pubitemid 350126615)
100. B.C. Yoo, E. Jeon, S.H. Hong, Y.K. Shin, H.J. Chang, and J.G. Park Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line Clin. Cancer Res. 10 2004 4176 4184 (Pubitemid 38812498)
101. D. Zhang, J.J. Zhang, and G.T. Liu The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells Neuropharmacology 52 2013 423 429
102. M. Zhang, J. Li, R. Geng, W. Ge, Y. Zhou, C. Zhang, Y. Cheng, and D. Geng The inhibition of ERK activation mediates the Protection of Necrostatin-1 on glutamate toxicity in HT-22 cells Neurotox. Res. 24 2013 64 70
103. G. Zhu, X. Wang, S. Wu, and Q. Li Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death Neurochem Int. 60 2012 400 408